Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
PR Newswire Asia
· *The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one..